...
首页> 外文期刊>Frontiers in Life Science >Antidiabetic effect of combined spices of Allium sativum, Zingiber officinale and Capsicum frutescens in alloxan-induced diabetic rats
【24h】

Antidiabetic effect of combined spices of Allium sativum, Zingiber officinale and Capsicum frutescens in alloxan-induced diabetic rats

机译:大蒜,姜和辣椒的混合香料对四氧嘧啶致糖尿病大鼠的抗糖尿病作用

获取原文
获取原文并翻译 | 示例
           

摘要

Allium sativum (garlic), Zingiber officinale (ginger) and Capsicum frutescens (cayenne pepper) are common dietary spices also traditionally used in the treatment of various diseases including diabetes mellitus. The antidiabetic activity of each individual spice is well documented, but their effect when combined is unknown. Polyherbalism is of current interest because polyherbal formulations enhance therapeutic action and reduce the concentrations of single herbs, thereby reducing adverse events. This study evaluated the hypoglycaemic activity of aqueous extract of combined garlic, ginger and cayenne pepper (GGCP) at different doses in alloxan-induced diabetic rats. Diabetic rats were treated with GGCP at 200mg and 500mg/kg body weight/day, or glibenclamide (5mg/kg body weight/day) for 7 days. GGCP extract significantly (p<0.05) lowered the elevated fasting blood glucose, lipid and haematological indices. The mixture markedly attenuated cellular toxicity, and reduced tubular degeneration and necrosis in the kidney, fatty degeneration and necrosis in the liver and pancreatic hyperplasia in diabetic rats. These effects were more pronounced at 500mg/kg and equipotent with glibenclamide, suggesting that in addition to its hypoglycaemic activity, GGCP protects the blood, kidney, liver and pancreas against diabetic injury. This is the first pilot study to evaluate a possible role for this spice mixture in the treatment of diabetes.
机译:大蒜(大蒜),姜(姜)和辣椒(辣椒)是常见的饮食香料,传统上也用于治疗多种疾病,包括糖尿病。每个单独的香料的抗糖尿病活性都有充分的文献记载,但是当它们合并使用时其作用尚不清楚。多草药疗法是当前关注的,因为多草药配方增强了治疗作用并降低了单一草药的浓度,从而减少了不良事件。这项研究评估了不同剂量的大蒜,生姜和辣椒辣椒(GGCP)的水提取物在四氧嘧啶诱导的糖尿病大鼠中的降血糖活性。糖尿病大鼠分别以200mg和500mg / kg体重/天的GGCP或格列苯脲(5mg / kg体重/天)的治疗7天。 GGCP提取物显着(p <0.05)降低了空腹血糖,血脂和血液学指标的升高。该混合物显着减弱了细胞毒性,并减少了糖尿病大鼠肾脏的肾小管变性和坏死,肝脏脂肪变性和坏死以及胰腺增生。这些作用在500mg / kg时更明显,与glibenclamide等效,表明GGCP除了具有降血糖作用外,还可以保护血液,肾脏,肝脏和胰腺免受糖尿病的损害。这是第一个评估这种香料混合物在糖尿病治疗中可能作用的初步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号